These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 7514710)

  • 21. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal.
    Shoblock JR; Maidment NT
    Neuroscience; 2007 Nov; 149(3):642-9. PubMed ID: 17905519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat.
    Holland LN; Shuster LC; Buccafusco JJ
    Neuropharmacology; 1993 Dec; 32(12):1387-95. PubMed ID: 8152529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence.
    Lutfy K; Parikh D; Lee DL; Liu Y; Ferrini MG; Hamid A; Friedman TC
    Neuroscience; 2016 Aug; 329():318-25. PubMed ID: 27208618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
    Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
    Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.
    Madhavan A; He L; Stuber GD; Bonci A; Whistler JL
    J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.
    Chen SL; Ma HI; Han JM; Lu RB; Tao PL; Law PY; Loh HH
    J Biomed Sci; 2010 Apr; 17(1):28. PubMed ID: 20403204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
    Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
    Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
    Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between laudanosine, GABA, and opioid subtype receptors: implication for laudanosine seizure activity.
    Katz Y; Weizman A; Pick CG; Pasternak GW; Liu L; Fonia O; Gavish M
    Brain Res; 1994 May; 646(2):235-41. PubMed ID: 8069669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
    Dunbar SA; Karamian I; Zhang J
    Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
    Walker EA; Sterious SN
    Br J Pharmacol; 2005 Aug; 145(7):975-83. PubMed ID: 15912139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.
    Kamei J; Ohsawa M; Saitoh A; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    J Pharmacol Exp Ther; 1995 Aug; 274(2):700-6. PubMed ID: 7636731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus.
    Hong M; Milne B; Jhamandas K
    Brain Res; 1993 Sep; 623(1):131-41. PubMed ID: 8221081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine does not mediate opioid withdrawal.
    Kreeger JS; Yukhananov RYu ; Larson AA
    Brain Res; 1994 Nov; 663(1):101-6. PubMed ID: 7850459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice.
    Menendez L; Andres-Trelles F; Hidalgo A; Baamonde A
    Brain Res; 1993 May; 611(2):264-71. PubMed ID: 8392894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine.
    Greenwald MK; Stitzer ML
    Drug Alcohol Depend; 1998 Dec; 53(1):17-30. PubMed ID: 10933337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
    Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
    J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.